RHINALAR NASAL MIST 25 MCG
FLUNISOLIDE : 25 MCG · DIN 02162687 · IVAX LABORATORIES INCORPORATED
Health Canada status: CANCELLED POST MARKET
What is RHINALAR NASAL MIST?
RHINALAR NASAL MIST 25 MCG contains FLUNISOLIDE : 25 MCG. It is listed in the Health Canada Drug Product Database under DIN 02162687, held by IVAX LABORATORIES INCORPORATED, supplied as SOLUTION ; SPRAY for NASAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Oct-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02162687 |
|---|---|
| Brand name | RHINALAR NASAL MIST |
| Generic / active ingredient | FLUNISOLIDE : 25 MCG |
| Manufacturer | IVAX LABORATORIES INCORPORATED |
| Strength | 25 MCG |
| Dosage form | SOLUTION ; SPRAY |
| Route of administration | NASAL |
| Schedule | Prescription |
| ATC code | R01AD04 FLUNISOLIDE |
| AHFS class | 52:08.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Oct-2015 |
| Original market date | 1996-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02162687 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2162687 |
| Brand name | RHINALAR NASAL MIST |
| Active ingredient / INN | FLUNISOLIDE : 25 MCG |
| ATC code | R01AD04 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R01 |
| AHFS class | 52:08.08 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | IVAX LABORATORIES INCORPORATED |
Which pack is which?
| Strength on the label | 25 MCG |
|---|---|
| Dosage form | SOLUTION ; SPRAY |
| Route | NASAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code R01AD04 FLUNISOLIDE. 0 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-FLUNISOLIDE NASAL SPRAY | 0.25 MG | METERED-DOSE PUMP | APOTEX INC | CANCELLED POST MARKET | DIN 02239288 |
| NOVO-FLUNISOLIDE | 25 MCG | SPRAY | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02230306 |
| PMS-FLUNISOLIDE | 0.025 % | SPRAY | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 01927167 |
| RATIO-FLUNISOLIDE | 25 MCG | SPRAY | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 00878790 |
| RHINALAR | .025 % | SPRAY | SYNTEX INC. | CANCELLED POST MARKET | DIN 00421456 |
How much does FLUNISOLIDE cost around the world?
FLUNISOLIDE is listed on 2 national price registers Nexara tracks, across 36 pack listings published on 2 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Italy | prezzo al pubblico (classe A) | 34 | 35 | 02 Sep 2026 |
| United States | acquisition | 1 | 1 | 03 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.